A low-cost biosensor, called Neosens, will allow doctors to diagnose sepsis in a matter of minutes. Neosens works by detecting interleukin 6, a messenger that’s secreted by newborns’ immune systems in response to a host of biological conditions. It’s also the main early marker for sepsis.

Neosens’ patented technology uses a machine learning program to make the device more reliable and reduce its detection time. The program can spot the marker almost without fail.

Sepsis is a life-threatening condition caused by an overactive immune response, generally following a bacterial infection. It’s a major cause of infant death worldwide. According to the World Health Organization, 2.9 million children under the age of five died of sepsis in 2017, mainly in low- and middle-income countries. However, early detection and treatment with antibiotics can considerably improve a patient’s outlook. (Image credit: EPFL)

For more information, visit here  .

Topics:
Age groups Biological sciences Biosensors Infants Medical

More From SAE Media Group

    Magazine cover
    Medical Design Briefs Magazine

    This article first appeared in the October, 2023 issue of Medical Design Briefs Magazine (Vol. 13 No. 10).

    Read more articles from this issue here.

    Read more articles from the archives here.